200 related articles for article (PubMed ID: 35211629)
1. Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren's Syndrome.
Fu J; Pu Y; Wang B; Li H; Yang X; Xie L; Shi H; Wang Z; Yin J; Zhan T; Shao Y; Chen C; Luo Q; Xu J; Zong Z; Wei X; Xiao W; Yu C; Zheng L
J Immunol Res; 2022; 2022():3210200. PubMed ID: 35211629
[TBL] [Abstract][Full Text] [Related]
2. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4
Fu J; Shi H; Wang B; Zhan T; Shao Y; Ye L; Wu S; Yu C; Zheng L
J Autoimmun; 2020 Feb; 107():102358. PubMed ID: 31757716
[TBL] [Abstract][Full Text] [Related]
3. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
4. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.
Nguyen CQ; Hu MH; Li Y; Stewart C; Peck AB
Arthritis Rheum; 2008 Mar; 58(3):734-43. PubMed ID: 18311793
[TBL] [Abstract][Full Text] [Related]
5. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
[TBL] [Abstract][Full Text] [Related]
6. IL-27 Regulated CD4
Qi J; Zhang Z; Tang X; Li W; Chen W; Yao G
Front Immunol; 2020; 11():1699. PubMed ID: 32849596
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells.
Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH
Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724
[TBL] [Abstract][Full Text] [Related]
8. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
[TBL] [Abstract][Full Text] [Related]
9. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
10. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
[TBL] [Abstract][Full Text] [Related]
11. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
[TBL] [Abstract][Full Text] [Related]
12. IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.
Nguyen CQ; Yin H; Lee BH; Chiorini JA; Peck AB
Lab Invest; 2011 Jan; 91(1):54-62. PubMed ID: 20856230
[TBL] [Abstract][Full Text] [Related]
13. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
14. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.
Sakai A; Sugawara Y; Kuroishi T; Sasano T; Sugawara S
J Immunol; 2008 Aug; 181(4):2898-906. PubMed ID: 18684981
[TBL] [Abstract][Full Text] [Related]
15. cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.
Takahashi H; Tsuboi H; Asashima H; Hirota T; Kondo Y; Moriyama M; Matsumoto I; Nakamura S; Sumida T
Clin Exp Immunol; 2017 Oct; 190(1):96-109. PubMed ID: 28621822
[TBL] [Abstract][Full Text] [Related]
16. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
[TBL] [Abstract][Full Text] [Related]
17. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation.
Huang Y; Yang G; Fei J; Wu Y; Yan J
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1977-1985. PubMed ID: 31950221
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
19. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
